Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT03949829

The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study

Conditions: Pre-Eclampsia, Atherosclerosis, Cardiovascular Diseases, Heart Disease in Women

Sex: Female
Ages: 35 Years – 55 Years
Healthy volunteers: No
Enrollment: 921
Sponsor: Klaus Fuglsang Kofoed

Location: Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen Copenhagen

Summary

Women with a history of preeclampsia (PE) have increased risk of hypertension and cardiovascular disease (CVD) later in life. Thus, PE is acknowledged as an independent risk factor for CVD, which is the number one cause of death in women in the western part of the world. Objective: The purpose of this study is to investigate 1) the prevalence of CVD after PE, 2) which women have the highest risk of developing CVD, 3) when early stages of CVD can be detected in women with previous PE and 4) how CVD progress over time. Methods: 1000 women with previous PE between the age of 35-55 years will be invited to participate in a follow-up study consisting of anthropometric measurements, blood pressure measurement, urine- and blood samples, cardiac CT-scan and questionnaires. Coronary atherosclerosis will be evaluated using CT imaging.The women will be compared with women with a formerly uncomplicated pregnancy, Summary: The study will provide new important information to guide future clinical follow-up, and potentially prevent disease and early death in a large group of women with a history of PE.

Eligibility Criteria

Inclusion Criteria \- Women with a history of preeclampsia Exclusion Criteria * Severe physical or mental disabilities * Lack of ability to speak and/or understand Danish language

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03949829). StuddyBuddy aggregates publicly available trial information.